Jiuyuan Genetic (02566) Releases Monthly Return for November 2025

Bulletin Express12-03

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 02566) announced its monthly return report for the period ended 30 November 2025, confirming no changes in share capital or treasury shares this month. According to the filing, the company maintains 109,096,785 H shares (listed on the Stock Exchange), 105,302,015 domestic shares, and 31,000,000 unlisted foreign shares, all with a par value of RMB 1 each. The total registered share capital remains at RMB 245,398,800.

The announcement shows that, as of the end of November 2025, the aforementioned H shares, domestic shares, and unlisted foreign shares have not undergone any increases or decreases. There were also no reported share repurchases, share options, warrants, or convertible securities. The document emphasizes that, as the company is incorporated in the People’s Republic of China, the concept of “authorised share capital” does not apply and the disclosed figures refer to its “registered share capital.”

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116020942?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 16:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116020942","market":"hk","top_or_hot":-1,"title":"Jiuyuan Genetic (02566) Releases Monthly Return for November 2025","media":"Bulletin Express","content":"<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 02566) announced its monthly return report for the period ended 30 November 2025, confirming no changes in share capital or treasury shares this month. According to the filing, the company maintains 109,096,785 H shares (listed on the Stock Exchange), 105,302,015 domestic shares, and 31,000,000 unlisted foreign shares, all with a par value of RMB 1 each. The total registered share capital remains at RMB 245,398,800.</p>\n<p>The announcement shows that, as of the end of November 2025, the aforementioned H shares, domestic shares, and unlisted foreign shares have not undergone any increases or decreases. There were also no reported share repurchases, share options, warrants, or convertible securities. The document emphasizes that, as the company is incorporated in the People’s Republic of China, the concept of “authorised share capital” does not apply and the disclosed figures refer to its “registered share capital.”</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiuyuan Genetic (02566) Releases Monthly Return for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiuyuan Genetic (02566) Releases Monthly Return for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 16:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 02566) announced its monthly return report for the period ended 30 November 2025, confirming no changes in share capital or treasury shares this month. According to the filing, the company maintains 109,096,785 H shares (listed on the Stock Exchange), 105,302,015 domestic shares, and 31,000,000 unlisted foreign shares, all with a par value of RMB 1 each. The total registered share capital remains at RMB 245,398,800.</p>\n<p>The announcement shows that, as of the end of November 2025, the aforementioned H shares, domestic shares, and unlisted foreign shares have not undergone any increases or decreases. There were also no reported share repurchases, share options, warrants, or convertible securities. The document emphasizes that, as the company is incorporated in the People’s Republic of China, the concept of “authorised share capital” does not apply and the disclosed figures refer to its “registered share capital.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02566","symbol_name":"九源基因","start_time":0,"source_url":"","article_id":"1116020942","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116020942","pubTimestamp":1764751991,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 02566) announced its monthly return report for the period ended 30 November 2025, confirming no changes in share capital or treasury...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02566":"九源基因"},"translate_title":"九原基因(02566)发布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02566":1},"content_text":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 02566) announced its monthly return report for the period ended 30 November 2025, confirming no changes in share capital or treasury shares this month. According to the filing, the company maintains 109,096,785 H shares (listed on the Stock Exchange), 105,302,015 domestic shares, and 31,000,000 unlisted foreign shares, all with a par value of RMB 1 each. The total registered share capital remains at RMB 245,398,800.\nThe announcement shows that, as of the end of November 2025, the aforementioned H shares, domestic shares, and unlisted foreign shares have not undergone any increases or decreases. There were also no reported share repurchases, share options, warrants, or convertible securities. The document emphasizes that, as the company is incorporated in the People’s Republic of China, the concept of “authorised share capital” does not apply and the disclosed figures refer to its “registered share capital.”","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116020942","isCrawlerRequest":true}